Loading
Life sciences · Journal article
International Journal of Reproduction Contraception Obstetrics and Gynecology · October 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background: Gestational diabetes mellitus is a common metabolic complication of pregnancy. Serum uric acid has been investigated as an inexpensive biomarker linked to insulin resistance and metabolic dysfunction. This study examined the relationship between maternal serum uric acid and its association with glycaemic control. Methods: This case-control study enrolled 120 pregnant women between 24 and 40 weeks of gestation- 60 with GDM and 60 normoglycaemic controls. Demographic and clinical data were recorded, and serum uric acid was measured using an enzymatic uricase-peroxidase method. We assessed its association with GDM, random blood sugar (RBS), glycated hemoglobin (HbA1c) and treatment modality were evaluated and receiver operating characteristic (ROC) analysis were performed. Results: Women with GDM were older and more often overweight or obese than controls. Serum uric acid was significantly higher in the GDM group: 50.0% of cases had levels above 5.7 mg/dl, compared with 18.33% of controls (p<0.003). Uric acid correlated with RBS (r=0.29, p=0.02) and, more strongly, with HbA1c (Spearman ρ=0.690, p<0.001). Women who required insulin had higher mean uric acid than those managed on medication alone (6.70±0.86 versus 5.35±1.18 mg/dl; p<0.001). ROC analysis gave an area under the curve of 0.7325, with an optimal cut-off of ≥5.1 mg/dl (sensitivity 71.67%, specificity 66.67%). Conclusions: Maternal serum uric acid was associated with GDM and with markers of poorer glycemic control and greater treatment intensity. It may be a useful adjunctive biomarker, but its moderate discriminatory power means it cannot stand alone as a diagnostic test.